Zusammenfassung
Die Herpes-Virus-(HSV-)assoziierte Keratitis ist die häufigste Ursache postinfektiöser, persistierender Hornhauttrübung und stellt weiterhin eine wichtige Indikation zur Keratoplastik dar. In den letzten Jahren lässt sich ein Wandel in der Epidemiologie der Infektion und ihren Behandlungsmöglichkeiten beobachten. Ziel dieses Beitrages ist es, eine Übersicht zur aktuellen Entwicklung und insbesondere zu spezifischen Aspekten der Keratoplastik nach HSV-Keratitis zu bieten.
Abstract
Herpes simplex viral (HSV) keratitis is the leading infectious cause of secondary visual loss in the western world. Corneal stromal scaring is still an important indication for penetrating keratoplasty. Over the past decades the epidemiology of HSV infection as well as treatment strategies have changed. This review will address these recent findings with a focus on specific aspects of keratoplasty subsequent to HSV keratitis.
Schlüsselwörter
Kornea - Herpes-simplex-Virus - Keratitis - Keratoplastik - Transplantation
Key words
cornea - herpes simplex virus - keratitis - keratoplasty - transplantation
Literatur
-
1
Akova Y A, Onat M, Duman S.
Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
Ocul Immunol Inflamm.
1999;
7 (1)
51-60
-
2
Al-Yousuf N, Mavrikakis I, Mavrikakis E. et al .
Penetrating keratoplasty: indications over a 10 year period.
Br J Ophthalmol.
2004;
88 (8)
998-1001
-
3
Allison A C, Eugui E M.
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
Transplantation.
2005;
80 (Suppl 2)
S181-S190
-
4
Beckingsale P, Mavrikakis I, Al-Yousuf N. et al .
Penetrating keratoplasty: outcomes from a corneal unit compared to national data.
Br J Ophthalmol.
2006;
90 (6)
728-731
-
5
Bertelmann E, Reinhard T, Pleyer U.
Stand der Immunprophylaxe und -therapie bei perforierender Keratoplastik. Eine Umfrage bei Mitgliedern der Sektion Kornea der DOG.
Ophthalmologe.
2003;
100 (12)
1031-1035
-
6
Beyer C F, Arens M Q, Hill G A. et al .
Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty.
Arch Ophthalmol.
1989;
107 (8)
1200-1205
-
7
Beyer C F, Hill J M, Reidy J J. et al .
Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1.
Invest Ophthalmol Vis Sci.
1990;
31 (5)
925-932
-
8
Biswas P S, Rouse B T.
Early events in HSV keratitis - setting the stage for a blinding disease.
Microbes Infect.
2005;
7 (4)
799-810
-
9
Biswas S, Suresh P, Bonshek R E. et al .
Graft failure in human donor corneas due to transmission of herpes simplex virus.
Br J Ophthalmol.
2000;
84 (7)
701-705
-
10
Cleator G M, Klapper P E, Dennett C. et al .
Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas.
Cornea.
1994;
13 (4)
294-304
-
11
Cobo L M, Coster D J, Rice N S. et al .
Prognosis and management of corneal transplantation for herpetic keratitis.
Arch Ophthalmol.
1980;
98 (10)
1755-1759
-
12
Cockerham G C, Bijwaard K, Sheng Z M. et al .
Primary graft failure: a clinicopathologic and molecular analysis.
Ophthalmology.
2000;
107 (11)
2083-2090; discussion 2090 - 2081
-
13
Cosar C B, Sridhar M S, Cohen E J. et al .
Indications for penetrating keratoplasty and associated procedures, 1996 - 2000.
Cornea.
2002;
21 (2)
148-151
-
14
Cursiefen C, Rummelt C, Kuchle M.
Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization.
Cornea.
2000;
19 (4)
526-533
-
15
Cursiefen C, Seitz B, Dana M R. et al .
Angiogenese und Lymphangiogenese in der Hornhaut. Pathogenese, klinische Bedeutung und Therapieoptionen.
Ophthalmologe.
2003;
100 (4)
292-299
-
16
Dana M R, Qian Y, Hamrah P.
Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection.
Cornea.
2000;
19 (5)
625-643
-
17
Davidorf J M.
Herpes simplex keratitis after LASIK.
J Refract Surg.
1998;
14 (6)
667
-
18
De Kesel R J, Koppen C, Ieven M. et al .
Primary graft failure caused by herpes simplex virus type 1.
Cornea.
2001;
20 (2)
187-190
-
19
Dhaliwal D K, Barnhorst D A, Romanowski Jr E. et al .
Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model.
Am J Ophthalmol.
1998;
125 (4)
488-492
-
20
Dhaliwal D K, Romanowski E G, Yates K A. et al .
Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
J Cataract Refract Surg.
2001;
27 (8)
1288-1293
-
21
Dorrepaal S J, Cao K Y, Slomovic A R.
Indications for penetrating keratoplasty in a tertiary referral centre in Canada, 1996 - 2004.
Can J Ophthalmol.
2007;
42 (2)
244-250
-
22
Ficker L A, Kirkness C M, Rice N S. et al .
The changing management and improved prognosis for corneal grafting in herpes simplex keratitis.
Ophthalmology.
1989;
96 (11)
1587-1596
-
23
Flowers C W, Chanq K Y, McLeod S D. et al .
Changing indications for penetrating keratoplasty, 1989 - 1993.
Cornea.
1995;
14 (6)
583-588
-
24
Gong N, Pleyer U, Vogt K. et al .
Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival.
Invest Ophthalmol Vis Sci.
2007;
48 (3)
1043-1052
-
25
Gore S M, Bird A G, Ross A J.
Prison rites: starting to inject inside.
Bmj.
1995;
311 (7013)
1135-1136
-
26
Harooni H, Reddy V, Root T. et al .
Bevacizumab for graft rejection.
Ophthalmology.
2007;
114 (10)
1950
-
27
Heiligenhaus A, Steuhl K P.
Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
Graefes Arch Clin Exp Ophthalmol.
1999;
237 (5)
435-438
-
28
Hendricks R L, Janowicz M, Tumpey T M.
Critical role of corneal Langerhans cells in the CD 4- but not CD 8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
J Immunol.
1992;
148 (8)
2522-2529
-
29
Hosseini H, Khalili M R.
Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).
Med Hypotheses.
2007;
69 (3)
568-570
-
30
Jarade E F, Tabbara K F.
Laser in situ keratomileusis in eyes with inactive herpetic keratitis.
Am J Ophthalmol.
2001;
132 (5)
779-780
-
31
Kaye S, Choudhary A.
Herpes simplex keratitis.
Prog Retin Eye Res.
2006;
25 (4)
355-380
-
32
Kaye S B, Baker K, Bonshek R. et al .
Human herpesviruses in the cornea.
Br J Ophthalmol.
2000;
84 (6)
563-571
-
33
Kersten A, Sundmacher R, Reinhard T.
Postoperative Komplikationen nach perforierender Keratoplastik in Herpesaugen: Differentialdiagnose, Therapie und prognostische Bedeutung.
Ophthalmologe.
1997;
94 (12)
889-896
-
34
Kinghorn G R.
Epidemiology of genital herpes.
J Int Med Res.
1994;
22 (Suppl 1)
14A-23A
-
35
Klebe S, Sykes P J, Coster D J. et al .
Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10.
Transplantation.
2001;
71 (9)
1214-1220
-
36
Larkin D F, Oral H B, Ring C J. et al .
Adenovirus-mediated gene delivery to the corneal endothelium.
Transplantation.
1996;
61 (3)
363-370
-
37
Legeais J M, Parc C, d’Hermies F. et al .
Nineteen years of penetrating keratoplasty in the Hotel-Dieu Hospital in Paris.
Cornea.
2001;
20 (6)
603-606
-
38
Lepisto A J, Frank G M, Hendricks R L.
How herpes simplex virus type 1 rescinds corneal privilege.
Chem Immunol Allergy.
2007;
92
203-212
-
39
Levy J, Lapid-Gortzak R, Klemperer I. et al .
Herpes simplex virus keratitis after laser in situ keratomileusis.
J Refract Surg.
2005;
21 (4)
400-402
-
40
Liekfeld A, Jaeckel C, Pleyer U. et al .
Kammerwasseranalyse bei Keratoplastikpatienten mit Keratitiden. Erste Resultate.
Ophthalmologe.
2001;
98 (5)
456-459
-
41
Liesegang T J.
Herpes simplex virus epidemiology and ocular importance.
Cornea.
2001;
20 (1)
1-13
-
42
Liu E, Slomovic A R.
Indications for penetrating keratoplasty in Canada, 1986 - 1995.
Cornea.
1997;
16 (4)
414-419
-
43
Liu Y, Hamrah P, Zhang Q. et al .
Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts.
J Exp Med.
2002;
195 (2)
259-268
-
44
Lomholt J A, Baggesen K, Ehlers N.
Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis.
Acta Ophthalmol Scand.
1995;
73 (1)
29-32
-
45
Mayer K, Reinhard T, Reis A. et al .
Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.
Graefes Arch Clin Exp Ophthalmol.
2003;
241 (12)
1051-1054
-
46
Metcalf J F, Hamilton D S, Reichert R W.
Herpetic keratitis in athymic (nude) mice.
Infect Immun.
1979;
26 (3)
1164-1171
-
47
Nicholls S M, Shimeld C, Easty D L. et al .
Recurrent herpes simplex after corneal transplantation in rats.
Invest Ophthalmol Vis Sci.
1996;
37 (2)
425-435
-
48
Patel N P, Kim T, Rapuano C J. et al .
Indications for and outcomes of repeat penetrating keratoplasty, 1989 - 1995.
Ophthalmology.
2000;
107 (4)
719-724
-
49
Pepose J S, Keadle T L, Morrison L A.
Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
Am J Ophthalmol.
2006;
141 (3)
547-557
-
50
Philipp W, Speicher L, Humpel C.
Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
Invest Ophthalmol Vis Sci.
2000;
41 (9)
2514-2522
-
51
Rao S N.
Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1 % with topical cyclosporine 0.05 %.
Am J Ophthalmol.
2006;
141 (4)
771-772
-
52
Rasquin F, Demols P, Schrooyen M. et al .
Primo-infection herpetique post-keratoplastie transfixiante.
Bull Soc Belge Ophtalmol.
1998;
268
79-85
-
53
Reis A, Reinhard T, Sundmacher R. et al .
Mycophenolatmofetil (CellCept) bei okularen immunologischen Störungen. Literaturübersicht mit 3 Kasuistiken.
Klin Monatsbl Augenheilkd.
1998;
213 (5)
257-261
-
54
Reis A, Reinhard T, Voiculescu A. et al .
Hochaktive antivirale und immunsuppressive Kombinationstherapie mit Acyclovir und Mycophenolatmofetil nach Keratoplastik bei herpetischer Grunderkrankung.
Klin Monatsbl Augenheilkd.
2001;
218 (3)
183-186
-
55
Remeijer L, Doornenbal P, Geerards A J. et al .
Newly acquired herpes simplex virus keratitis after penetrating keratoplasty.
Ophthalmology.
1997;
104 (4)
648-652
-
56
Remeijer L, Maertzdorf J, Buitenwerf J. et al .
Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
Invest Ophthalmol Vis Sci.
2002;
43 (2)
358-363
-
57
Remeijer L, Maertzdorf J, Doornenbal P. et al .
Herpes simplex virus 1 transmission through corneal transplantation.
Lancet.
2001;
357 (9254)
442
-
58
Rezende R A, Uchoa U B, Raber I M. et al .
New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty.
Am J Ophthalmol.
2004;
137 (3)
415-419
-
59
Ritter T, Gong N, Pleyer U.
Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?.
Br J Ophthalmol.
2005;
89 (6)
648-649
-
60
Robert P Y, Adenis J P, Denis F. et al .
Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients.
J Med Virol.
2003;
71 (1)
69-74
-
61
Robert P Y, Adenis J P, Pleyer U.
Wie „sicher” ist das Hornhauttransplantat? - Ein Beitrag zum Risiko der HSV-Transmission durch Hornhauttransplantation.
Klin Monatsbl Augenheilkd.
2005;
222 (11)
870-873
-
62
Robert P Y, Liekfeld A, Metzner S. et al .
Specific antibody production in herpes keratitis: intraocular inflammation and corneal neovascularisation as predicting factors.
Graefes Arch Clin Exp Ophthalmol.
2006;
244 (2)
210-215
-
63
Sundmacher R.
Die Pathophysiologie der Herpes-simplex-Rezidive.
Klin Monatsbl Augenheilkd.
1977;
170 (4)
613-621
-
64
Sundmacher R, Neumann-Haefelin D.
Keratitis metaherpetica - Klinische und virologische Befunde.
Klin Monatsbl Augenheilkd.
1976;
169 (6)
728-737
-
65
Sundmacher R, Stefansson A, Mackensen G.
Verlaufsbeobachtungen nach Keratoplastik.
Fortschr Ophthalmol.
1983;
80 (3)
224-227
-
66
Tambasco F P, Cohen E J, Nguyen L H. et al .
Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
Arch Ophthalmol.
1999;
117 (4)
445-449
-
67
Rooij van J, Rijneveld W J, Remeijer L. et al .
Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial.
Ophthalmology.
2003;
110 (10)
1916-1919; discussion 1919
-
68
Volker-Dieben H J, Claas F H, Schreuder G M. et al .
Beneficial effect of HLA-DR matching on the survival of corneal allografts.
Transplantation.
2000;
70 (4)
640-648
-
69
Volker-Dieben H J, Kok-Alphen C C, D’Amaro van J. et al .
The effect of prospective HLA-A and -B matching in 288 penetrating keratoplasties for herpes simplex keratitis.
Acta Ophthalmol (Copenh).
1984;
62 (4)
513-523
-
70
Weiss H.
Epidemiology of herpes simplex virus type 2 infection in the developing world.
Herpes.
2004;
11 (Suppl 1)
24A-35A
-
71
Xu F, Schillinger J A, Sternberg M R. et al .
Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988 - 1994.
J Infect Dis.
2002;
185 (8)
1019-1024
-
72
Yahalom C, Mechoulam H, Solomon A. et al .
Forty years of changing indications in penetrating keratoplasty in Israel.
Cornea.
2005;
24 (3)
256-258
-
73
Zheng M, Schwarz M A, Lee S. et al .
Control of stromal keratitis by inhibition of neovascularization.
Am J Pathol.
2001;
159 (3)
1021-1029
-
74
Zheng X, Loutsch J M, Shimomura Y. et al .
Reactivation of herpes virus after lamellar keratoplasty.
Jpn J Ophthalmol.
1999;
43 (4)
257-261
Prof. Uwe Pleyer
Universitäts-Augenklinik, Charité Campus Virchow-Klinik
Augustenburger Platz 1
13353 Berlin
Telefon: ++ 49/30/4 50 55 41 31
Fax: ++ 49/30/4 50 55 49 00
eMail: Uwe.pleyer@charite.de
